JamesFMarkmannMD

Transplantation

Professor, Surgery-Massachusetts General Hospital, Harvard Medical School

Dr. Markmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Spruce St
Fl 4
Philadelphia, PA 19104
Phone+1 215-615-4949

Fax+1 215-662-2244

Efficacy of Islet After Kidney Transplantation Start of enrollment: 2007 Jan 01
Completed
Phase 3
Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients Start of enrollment: 2009 May 01
Completed
Phase 1, Phase 2
Research Study of ATG and Rituximab in Renal Transplantation Start of enrollment: 2011 Jul 25
Terminated
Early Phase 1
Reference Group Trial for The ONE Study Start of enrollment: 2012 Dec 01
Completed
Phase 4
Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study) Start of enrollment: 2014 May 01
Completed
Phase 1
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant Start of enrollment: 2017 Jan 01
Completed
Phase 2
Liver Transplantation With Tregs at MGH Start of enrollment: 2019 Mar 29
Active, not recruiting
Phase 1, Phase 2
OCS Liver PROTECT Continued Access Protocol Start of enrollment: 2020 Feb 03
Completed
Not Applicable
OCS Liver DCD Trial Start of enrollment: 2020 Jul 24
Active, not recruiting
Not Applicable
Join now to see all

PubMed

Another Detrimental Effect of Immunosuppression: Metabolic Syndrome.
Charles Rickert, James Markmann
Transplantation. 2024-11-01
1 citations
Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen.
Lisa Kojima, Miho Akabane, Matthew Murray, Michael Fruscione, Daiki Soma
Liver Transplantation. 2024-08-23
11 citations
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule.
Moufida Ben Nasr, Vera Usuelli, Sergio Dellepiane, Andy Joe Seelam, Teresa Vanessa Fiorentino
Cell Metabolism. 2024-06-04

Journal Articles

Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?
Theodoros Michelakos, Dimitrios Xourafas, David Berger, James F Markmann, Cristina R Ferrone, Motaz Qadan, Kenneth K Tanabe, Joel T Adler, Nahel Elias, Heidi Yeh, Madh..., Journal of gastrointestinal surgery
Signatures of Tolerance or Immunosuppression?
James Markmann, MD, American journal of transplantation

Vertex Releases New Data on Potential Cure for Type 1 DiabetesJune 21st, 2022
First Patient Gains Insulin Independence with Novel Stem Cell-Derived Islet Cell TherapyJune 7th, 2022
Stem Cell Transplants Promising so Far in Type 1 DiabetesJune 7th, 2022
Join now to see all

Mechanisms Of B Cell-Dependent Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2012
Mechanisms Of B Cell-Dependent Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2011
Regulation And Counter-Regulation In TransplantationNational Institute Of Allergy And Infectious Diseases2010
Mechanism Of Anti-Cd45 Induced Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2007–2010
Regulatory T Cells In Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2007–2008
Mechanism Of Anti-Cd45 Induced Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2006–2007
Regulatory T Cells In Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2004–2007
Mechanisms Of Acquired Central Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2001–2003
Gene Transfer For Autoimmune Beta Cell Damage PreventionNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002